[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334601-105":59,"doc-detail-334601-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gad2-is-a-highly-specific-marker-for-neuroendocrine-neoplasms-of-the-pancreas","GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas","","Glutamate decarboxylase 2 (GAD2) functions as a key inhibitory neurotransmitter and is involved in insulin-producing β cells in pancreatic islets. Because its expression is largely limited to a small set of normal cell types, GAD2 can serve as a potential immunohistochemical diagnostic marker. Using a tissue microarray with 19,202 samples across 152 tumor entities and 608 normal-tissue samples, GAD2 staining was largely brain and pancreatic islet-restricted and showed strong usefulness for identifying pancreatic origin of neuroendocrine neoplasms.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gad2-is-a-highly-specific-marker-for-neuroendocrine-neoplasms-of-the-pancreas/334601/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gad2-is-a-highly-specific-marker-for-neuroendocrine-neoplasms-of-the-pancreas/334601.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What makes GAD2 a potential diagnostic marker for pancreatic neuroendocrine neoplasms?","Question",{"text":112,"@type":113},"GAD2 is a crucial inhibitory neurotransmitter and its expression in normal tissues is restricted mainly to the brain and pancreatic islet cells, supporting its immunohistochemical diagnostic value.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was GAD2 diagnostic utility assessed in the study?",{"text":117,"@type":113},"The study evaluated GAD2 immunohistochemistry using a tissue microarray containing 19,202 samples from 152 tumor entities and 608 samples from 76 normal tissue types.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic performance did GAD2 show for determining pancreatic origin?",{"text":121,"@type":113},"GAD2 sensitivity was 64.2% with specificity 96.3%, indicating strong specificity for pancreatic origin in neuroendocrine neoplasms when the primary site is unknown.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334601,1790828060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","GAD2 Is a Highly Specific Marker for Neuroendocrine  \nNeoplasms of the Pancreas  \nMaximilian Lennartz, MD,* Nick Benjamin Dünnebier,* Doris Höﬂmayer, MD,* Sebastian Dwertmann Rico, MD,* Simon Kind, MD,* Viktor Reiswich, MD,* Florian Viehweger, MD,* Florian Lutz, MD,* Christoph Fraune, MD,* Natalia Gorbokon, MD,* Andreas M. Luebke, MD,* Claudia Hube-Magg, PhD,* Franziska Büscheck, MD,* Anne Menz, MD,* Ria Uhlig, MD,* Till Krech, MD,*† Andrea Hinsch, MD,* Eike Burandt, MD,* Guido Sauter, MD,* Ronald Simon, PhD,* Martina Kluth, PhD,* Stefan Steurer, MD,* Andreas H. Marx, MD,‡ Patrick Lebok, MD,*† David Dum, MD,* Sarah Minner, MD,* Frank Jacobsen, MD,* Till S. Clauditz, MD,* and Christian Bernreuther, MD*  \nAbstract: Glutamate decarboxylase 2 (GAD2) is the most important inhibitory neurotransmitter and plays a role in insulinproducing β cells of pancreatic islets. The limitation of GAD2 expression to a few normal cell types makes GAD2 a potential immunohistochemical diagnostic marker. To evaluate the diagnostic utility of GAD2 immunohistochemistry, a tissue microarray containing 19,202 samples from 152 different tumor entities and 608 samples of 76 different normal tissue types was analyzed. In normal tissues, GAD2 staining was restricted to brain and pancreatic islet cells. GAD2 staining was seen in 20 (13.2%) of 152 tumor categories, including 5 (3.3%) tumor categories containing at least 1 strongly positive case. GAD2  \nFrom the *Institute of Pathology, University Medical Center HamburgEppendorf, Hamburg; †Institute of Pathology, Clinical Center Osnabrueck, Osnabrueck; and ‡Department of Pathology, Academic Hospital Fuerth, Fuerth Germany.  \nC.B., M.L., N.B.D., R. S., M.K., and G. S.: contributed to the conception, design, data collection, data analysis, and manuscript writing. M.L., C.B., N.B.D., D.H., S.D.R., S.K., V.R., F.V., F.L., C.F., N.G., A.M.L., F.B., A.M., R.U., T.K., A.H., E.B., S. S., A.H.M.,  \nP.L., D.D., S.M., F.J., and T.S.C.: participated in pathology data analysis, data interpretation, and collection of samples M.L., R. S., M.K., and C.H.M.: data analysis C.B., R. S., and G. S.: study supervision.  \nConﬂicts of Interest and Source of Funding: The antibodies against GAD2 (MSVA-602M), insulin (HMV-308), and c-peptide (HMV- 363) were provided by MS Validated Antibodies GmbH (owned by a family member of G. S.) . For the remaining authors none were declared.  \nCorrespondence: Ronald Simon, PhD, Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg 20246, Germany (e-mail: [r.simon@uke.de](r.simon@uke.de)) .  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, [www.ajsp.com](www.ajsp.com).  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nimmunostaining was most commonly seen in neuroendocrine carcinomas (58.3%) and neuroendocrine tumors (63.2%) of the pancreas, followed by granular cell tumors (37 .0%) and neuroendocrine tumors of the lung (11 . 1%) . GAD2 was only occasionally ( \u003C 10% of cases) seen in 16 other tumor entities including paraganglioma, medullary thyroid carcinoma, and small cell neuroendocrine carcinoma of the urinary bladder. Data on GAD2 and progesterone receptor (PR) expression (from a previous study) were available for 95 pancreatic and 380 extrapancreatic neuroendocrine neoplasms. For determining a pancreatic origin of a neuroendocrine neoplasm, the sensitivity of GAD2 was 64.2% and speciﬁcity 96.3%, while the sensitivity of PR was 56 . 8% and speciﬁcity 92 .6% . The combination of PR and GAD","cbCaiiJOHQhvbP67","https://ap.wps.com/l/cbCaiiJOHQhvbP67","pdf",803344,"English","# Abstract\n# Methods and Tissue Microarray Analysis\n# Staining Distribution in Normal and Tumor Tissues\n# Diagnostic Performance for Pancreatic Origin\n# Biological Background of GAD2 in Neuroendocrine Context","[{\"question\":\"What makes GAD2 a potential diagnostic marker for pancreatic neuroendocrine neoplasms?\",\"answer\":\"GAD2 is a crucial inhibitory neurotransmitter and its expression in normal tissues is restricted mainly to the brain and pancreatic islet cells, supporting its immunohistochemical diagnostic value.\"},{\"question\":\"How was GAD2 diagnostic utility assessed in the study?\",\"answer\":\"The study evaluated GAD2 immunohistochemistry using a tissue microarray containing 19,202 samples from 152 tumor entities and 608 samples from 76 normal tissue types.\"},{\"question\":\"What diagnostic performance did GAD2 show for determining pancreatic origin?\",\"answer\":\"GAD2 sensitivity was 64.2% with specificity 96.3%, indicating strong specificity for pancreatic origin in neuroendocrine neoplasms when the primary site is unknown.\"}]","GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas | PDF",1790007434,25]